Jubilant Pharma: Good Drugs, Fully-Valued Bonds
We initiate our coverage of Jubilant Pharma Ltd (1164252D IN) (JPL) which is ranked top 2-3 global pharmaceutical company in the...
509 Views
Morning Views Asia: Fosun International, Glenmark Pharmaceuticals, Modernland Realty, Softbank Group
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...
415 Views
Glenmark Pharma: Approval for Covid-19 Oral Drug
In Unlock 1 Ill-Effects: Boon for the Consumer Discretionary? we highlighted the current covid 19 scenario where there is not a single trace of...
402 Views
Asia HY Monthly - Takeaways From China's Two Sessions (2020) - Lucror Analytics
From an investor’s perspective, the month of May was dominated by two issues: the likely rate of the post-pandemic economic recovery, and mounting...
406 Views
Asia HY Trade Recommendations - May 2020 - Lucror Analytics
The Asia HY Trade Recommendations report for the month of May includes a summary of our recommendations. The report also features relative-value...
407 Views